TNGX - Tango Therapeutics GAAP EPS of -$0.33 beats by $0.03 revenue of $6.41M beats by $0.09M
2023-03-27 07:40:35 ET
- Tango Therapeutics press release ( NASDAQ: TNGX ): Q4 GAAP EPS of -$0.33 beats by $0.03 .
- Revenue of $6.41M (+12.1% Y/Y) beats by $0.09M .
-
As of December 31, 2022, the Company held $366.1 million in cash, cash equivalents and marketable securities, which the Company believes to be sufficient to fund operations into 2025.
For further details see:
Tango Therapeutics GAAP EPS of -$0.33 beats by $0.03, revenue of $6.41M beats by $0.09M